Your cart is currently empty!
Sweden joins Germany, France, and 15 other countries in suspending AstraZeneca’s vaccine over possible side effects
Multiple countries have paused the use of AstraZeneca’s COVID-19 vaccine as a precaution while investigators look into cases of blood clots among vaccinated people.
Austrian authorities said March 7 that a 49-year-old woman had died as a result of severe coagulation disorder after taking the shot, and that a 35-year-old had developed blood clots in the lungs, but was recovering. Both had received vaccines from the same batch, the authorities said.
Danish authorities said on March 10 that one person who had clots after receiving the vaccine had died.
The European Medicines Agency (EMA) on the same day noted one death in a person with multiple blood clots after receiving the shots, and one person who had been hospitalized from a blood clot in their lung. It didn’t specifically say whether these were the same as the two incidents reported in Austria. The EMA noted two other “thrombotic events” in people who had received the vaccines, without giving details.
And on Sunday, the Dutch said there had been six new reports of clotting and thrombocytopenia — low platelet count — in adults under 50 in Denmark and Norway over that weekend
